Viking Therapeutics Inc. (VKTX)
NASDAQ · Healthcare
Viking Therapeutics Inc. Shareholder Equity 2014–2025
Viking Therapeutics Inc. annual shareholder equity history from 2014 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Viking Therapeutics Inc. shareholder equity as of December 31, 2025: 639.1M, a 27.40% decrease year-over-year.
- Viking Therapeutics Inc. shareholder equity for 2025 were 639.1M, a 27.40% decrease from 2024.
- Viking Therapeutics Inc. shareholder equity for 2024 were 880.3M, a 152.65% increase from 2023.
- Viking Therapeutics Inc. shareholder equity for 2023 were 348.4M, a 139.76% increase from 2022.
- Viking Therapeutics Inc. shareholder equity for 2022 were 145.3M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Viking Therapeutics Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $639 |
| 2024 | $880 |
| 2023 | $348 |
| 2022 | $145 |
| 2021 | $202 |
| 2020 | $244 |
| 2019 | $277 |
| 2018 | $298 |
| 2017 | $13 |
| 2016 | $8 |
| 2015 | $9 |
| 2014 | $-22 |
Viking Therapeutics Inc. Shareholder Equity — FAQ
Viking Therapeutics Inc. (VKTX) shareholder equity over the last 12 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see VKTX's shareholder equity history?
The chart and table above show Viking Therapeutics Inc.'s shareholder equity by year and by quarter, including the growth rate.